Cytosorbents

+$0.02 (+1.07%) Today
$0.00 (0.00%) As of 9:59 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytosorbents and other ETFs, options, and stocks.

About CTSO

CytoSorbents Corp. engages in the critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio include CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb.

CEO
Phillip P. Chan
Employees
221
Headquarters
Monmouth Junction, New Jersey
Founded
2002

CTSO Key Statistics

Market cap
82.33M
Price-Earnings ratio
—
Dividend yield
—
Average volume
216.99K
High today
$1.96
Low today
$1.83
Open price
$1.85
Volume
151.37K
52 Week high
$9.80
52 Week low
$1.78

CTSO Earnings

-$0.21
-$0.14
-$0.07
-$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 2, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure